Search research articles
Contact Us
Filters
Showing results (211-220 of 222) with videos related to
Page
of 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Stefanie Fischer, Torgrim Tandstad, Matthew Wheater, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy
Angelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2023
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
Gazanfer Belge, Cansu Dumlupinar, Tim Nestler, et al.
Journal of Cancer Research and Clinical Oncology
|
March 11, 2017
Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer
Simon Dulz, Niels H Asselborn, Klaus-Peter Dieckmann, et al.
World Journal of Urology
|
March 8, 2021
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Therapeutic Advances in Medical Oncology
|
April 7, 2022
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
Klaus-Peter Dieckmann, Tomas Pokrivcak, Lajos Geczi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Urologia Internationalis
|
January 7, 2021
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Urologia Internationalis
|
January 24, 2021
Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 222) with videos related to
Sort By:
Page
of 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Stefanie Fischer, Torgrim Tandstad, Matthew Wheater, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy
Angelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2023
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
Gazanfer Belge, Cansu Dumlupinar, Tim Nestler, et al.
Journal of Cancer Research and Clinical Oncology
|
March 11, 2017
Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer
Simon Dulz, Niels H Asselborn, Klaus-Peter Dieckmann, et al.
World Journal of Urology
|
March 8, 2021
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Therapeutic Advances in Medical Oncology
|
April 7, 2022
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
Klaus-Peter Dieckmann, Tomas Pokrivcak, Lajos Geczi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Urologia Internationalis
|
January 7, 2021
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Urologia Internationalis
|
January 24, 2021
Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Page
of 23